10月10日，英科医疗涨5.23%，截至发稿，报38.62元/股，成交3.91亿元，换手率2.25%，总市值252.88 亿元。 资料显示，英科医疗科技股份有限公司位于山东省淄博市临淄区齐鲁化学工业园清田路18号,香港湾仔 皇后大道东248号阳光中心40楼，成立日期2009年7月20日，上市日期2017年7月21日，公司主营业务涉 及涵盖个人防护、康复护理、其他产品三大板块。主营业务收入构成为：个人防护类91.47%，康复护 理类4.75%，其他产品3.77%。 从基金十大重仓股角度 大成创业板两年定开混合A（160926）基金经理为邹建。 截至发稿，邹建累计任职时间4年259天，现任基金资产总规模10.86亿元，任职期间最佳基金回报 12.49%， 任职期间最差基金回报-21.29%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 数据显示，大成基金旗下1只基金重仓英科医疗。大成创业板两年定开混合A（160926）二季度增持12 万股，持有股数84 ...

Group 1 - The core viewpoint of the news is that Yingke Medical has seen a significant increase in its stock price, rising by 5.33% to 38.76 CNY per share, with a trading volume of 444 million CNY and a turnover rate of 2.54%, resulting in a total market capitalization of 25.38 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] - The company is located in Zibo City, Shandong Province, and has its Hong Kong office at 40/F, Sunshine Center, 248 Queen's Road East, Wanchai [1] Group 2 - From the perspective of fund holdings, a fund under Zheshang Securities Asset Management has a significant position in Yingke Medical, with Zheshang Huijin Quantitative Selected Stocks A (011824) holding 40,200 shares, accounting for 0.75% of the fund's net value, making it the second-largest holding [2] - The fund has achieved a year-to-date return of 27.29%, ranking 2094 out of 4220 in its category, and a one-year return of 58.4%, ranking 1473 out of 3824 [2] - The fund manager, Chen Gujun, has been in position for 5 years and 251 days, with the fund's total asset size at 204 million CNY and a best return of 35.77% during his tenure [3]

9月26日，英科医疗盘中上涨2.01%，截至10:22，报37.54元/股，成交1.71亿元，换手率1.00%，总市值 245.81亿元。 资金流向方面，主力资金净流出745.45万元，特大单买入412.42万元，占比2.41%，卖出658.84万元，占 比3.86%；大单买入2395.34万元，占比14.02%，卖出2894.37万元，占比16.94%。 英科医疗今年以来股价涨49.08%，近5个交易日涨5.27%，近20日涨2.21%，近60日涨46.64%。 资料显示，英科医疗科技股份有限公司位于山东省淄博市临淄区齐鲁化学工业园清田路18号,香港湾仔 皇后大道东248号阳光中心40楼，成立日期2009年7月20日，上市日期2017年7月21日，公司主营业务涉 及涵盖个人防护、康复护理、其他产品三大板块。主营业务收入构成为：个人防护类91.47%，康复护 理类4.75%，其他产品3.77%。 英科医疗所属申万行业为：医药生物-医疗器械-医疗耗材。所属概念板块包括：医用耗材、智慧医疗、 抗原检测、医疗器械、跨境电商等。 截至6月30日，英科医疗股东户数6.00万，较上期减少2.96%；人均流通股7825股， ...

英科医疗今年以来股价涨46.94%，近5个交易日涨3.99%，近20日跌1.73%，近60日涨45.15%。 资料显示，英科医疗科技股份有限公司位于山东省淄博市临淄区齐鲁化学工业园清田路18号,香港湾仔 皇后大道东248号阳光中心40楼，成立日期2009年7月20日，上市日期2017年7月21日，公司主营业务涉 及涵盖个人防护、康复护理、其他产品三大板块。主营业务收入构成为：个人防护类91.47%，康复护 理类4.75%，其他产品3.77%。 9月25日，英科医疗盘中下跌2.01%，截至13:50，报37.00元/股，成交4.68亿元，换手率2.67%，总市值 242.27亿元。 资金流向方面，主力资金净流出1567.62万元，特大单买入1279.07万元，占比2.73%，卖出2541.32万 元，占比5.43%；大单买入8113.51万元，占比17.34%，卖出8418.87万元，占比17.99%。 截至6月30日，英科医疗股东户数6.00万，较上期减少2.96%；人均流通股7825股，较上期增加3.07%。 2025年1月-6月，英科医疗实现营业收入49.13亿元，同比增长8.90%；归母净利润7.10亿 ...

Group 1 - The core point of the news is that Yingke Medical's stock price has dropped by 5.01% to 34.16 CNY per share, with a trading volume of 546 million CNY and a turnover rate of 3.38%, resulting in a total market capitalization of 22.368 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, is located in Zibo City, Shandong Province, and operates in three main business segments: personal protection (90.31% of revenue), rehabilitation care (4.81%), and other products (4.89%) [1] Group 2 - From the perspective of major fund holdings, Dachen Fund has one fund heavily invested in Yingke Medical, specifically the Dachen Growth Enterprise Two-Year Open Mixed A Fund (160926), which increased its holdings by 120,000 shares in the second quarter, bringing the total to 848,900 shares, accounting for 3.37% of the fund's net value [2] - The Dachen Growth Enterprise Two-Year Open Mixed A Fund has a current scale of 449 million CNY and has achieved a year-to-date return of 22.17%, ranking 3332 out of 8180 in its category, with a one-year return of 39.93%, ranking 3389 out of 7978 [2]

Core Viewpoint - The stock price of Kefu Medical closed at 42.00 yuan on August 20, 2025, reflecting a decline of 1.50% from the previous trading day [1] Company Overview - Kefu Medical specializes in the research, development, production, and sales of medical devices, with products spanning rehabilitation care, medical electronics, and consumables [1] - In the first quarter of 2025, the company reported a revenue of 738 million yuan and a net profit attributable to shareholders of 91.43 million yuan [1] Shareholder Activity - On August 20, 2025, Kefu Medical announced that its controlling shareholder, Changsha Medical Investment Co., Ltd., has released the pledge of 8.01 million shares, which accounts for 9.41% of its holdings and 3.83% of the company's total share capital [1] Capital Flow - On August 20, 2025, the net outflow of main funds was 5.0974 million yuan, while the cumulative net inflow of main funds over the past five trading days reached 119.7495 million yuan [1]

Group 1 - The stock price of Kefu Medical closed at 42.61 yuan on August 18, 2025, with an increase of 0.10 yuan, representing a rise of 0.24% [1] - The stock experienced significant volatility during the day, reaching a high of 45.34 yuan and a low of 42.40 yuan, resulting in an amplitude of 6.92% [1] - The trading volume for the day was 4.01 billion yuan, with a turnover rate of 4.76% [1] Group 2 - Kefu Medical's main business includes the research, production, and sales of medical devices, covering areas such as rehabilitation care, medical electronics, and consumables [1] - The company operates in sectors including medical devices, elderly care concepts, and e-commerce concepts [1] Group 3 - On August 18, Kefu Medical's stock price experienced a rapid decline in the morning, with a drop of over 2% within 5 minutes, but gradually stabilized thereafter [1] - The net inflow of main funds on August 18 was 13.76 million yuan, with a cumulative net inflow of 127 million yuan over the past five trading days [1]

Group 1 - The stock price of Jinhai Medical as of August 6, 2025, is 24.98 yuan, down 0.50 yuan from the previous trading day's closing price, representing a decline of 1.96% [1] - The opening price for the day was 25.50 yuan, with a highest price of 25.55 yuan and a lowest price of 24.67 yuan, resulting in a trading volume of 24,581 hands and a transaction amount of 0.62 billion yuan [1] - Jinhai Medical operates in the medical device industry, focusing on the research, production, and sales of medical devices, with products spanning various medical fields including rehabilitation care and medical consumables [1] Group 2 - On August 6, a block trade occurred involving 100,000 shares at a transaction amount of 2.411 million yuan, with a transaction price of 24.11 yuan, which is a discount of 3.48% relative to the day's closing price [1] - The buyer of this block trade was Guoxin Securities Shandong Branch, while the seller was GF Securities Huizhou Xiapu Road Branch [1] - In the past month, Jinhai Medical has recorded a total of 6 block trades, with a cumulative transaction amount of 18.1655 million yuan [1]

Group 1 - The core viewpoint of the article highlights that Kefu Medical's stock price has decreased by 0.97% to 37.59 yuan as of August 6, 2025, with a trading volume of 24,400 hands and a turnover of 92 million yuan [1] - Kefu Medical specializes in the research, production, and sales of medical devices, covering areas such as rehabilitation care, medical electronics, and consumables [1] - The company is planning to list in Hong Kong, with a current market value of approximately 7.9 billion yuan [1] Group 2 - Market rumors suggest that regulatory authorities may raise the market capitalization threshold for A-share companies to list in Hong Kong to 20 billion yuan, which could impact smaller companies [1] - On August 6, a block trade occurred involving 230,500 shares, amounting to 8.31 million yuan, at a discount of 4.07% [1] - On the same day, the net outflow of main funds was 16.38 million yuan, accounting for 0.22% of the circulating market value, while the net inflow over the past five days was 11.95 million yuan, representing 0.16% of the circulating market value [1]

Core Viewpoint - The stock price of Kefu Medical closed at 37.96 yuan on August 5, 2025, reflecting a decline of 1.43% from the previous trading day [1] Company Overview - Kefu Medical specializes in the research, development, production, and sales of medical devices, with products spanning rehabilitation care, medical electronics, and consumables [1] - The company operates within the medical device sector and is part of the Hunan region market [1] Market Activity - On August 5, the trading volume for Kefu Medical was 31,767 hands, with a transaction amount of 1.21 billion yuan, resulting in a turnover rate of 1.64% [1] - Recent data indicates a net outflow of main funds amounting to 13.44 million yuan on August 5, which represents 0.18% of the circulating market value [1] - However, over the past five days, the overall trend for main funds has shown a net inflow of 33.91 million yuan, accounting for 0.46% of the circulating market value [1]